The Value of Routine Intravenous Tranexamic Acid in Total Hip Arthroplasty: A Preliminary Study
暂无分享,去创建一个
G. Hooper | C. Frampton | D. Kieser | J. Chin | J. Blackett
[1] P. Kang,et al. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration. , 2016, The Journal of bone and joint surgery. American volume.
[2] Jinwei Xie,et al. Combined use of Intravenous and Topical Tranexamic Acid following Cementless Total Hip Arthroplasty: A Randomised Clinical Trial , 2016, Hip international : the journal of clinical and experimental research on hip pathology and therapy.
[3] S. Nishihara,et al. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis? , 2015, The bone & joint journal.
[4] Gary Hooper,et al. Current trends and projections in the utilisation rates of hip and knee replacement in New Zealand from 2001 to 2026. , 2014, The New Zealand medical journal.
[5] M. Mazumdar,et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety , 2014, BMJ : British Medical Journal.
[6] L. Beckert,et al. Pseudotumours and IgG4-related disease: a case report. , 2014, The New Zealand medical journal.
[7] Todd C. Kelley,et al. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty , 2014, Transfusion.
[8] V. Trkulja,et al. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial , 2014, Transfusion.
[9] V. Selvaratnam,et al. Does Pre-Operative Tranexamic Acid Increase the Incidence of Thromboembolism in Primary Lower Limb Arthroplasty? , 2013 .
[10] Z. Straka,et al. Topical use of tranexamic acid in cardiac surgery—A review and meta-analysis of four randomized controlled trials , 2013 .
[11] P. Black,et al. Enhanced recovery after surgery (ERAS) protocols: Time to change practice? , 2011, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.
[12] S. Kurtz,et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. , 2007, The Journal of bone and joint surgery. American volume.
[13] A. Davenport. Faculty Opinions recommendation of The risk associated with aprotinin in cardiac surgery. , 2006 .
[14] I. C. Tudor,et al. The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.
[15] K. Ho,et al. Use of Intravenous Tranexamic Acid to Reduce Allogeneic Blood Transfusion in Total Hip and Knee Arthroplasty: A Meta-analysis , 2003, Anaesthesia and intensive care.
[16] Hongbo Yu,et al. Risks of blood transfusion and their prevention. , 2003, Clinical advances in hematology & oncology : H&O.
[17] Primer on statistical significance and P values. , 2001, Effective clinical practice : ECP.